SEC Filing Analysis: SPRUCE BIOSCIENCES, INC. (SPRB)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director was granted 3,400 stock options as a routine component of their compensation package.
• Market Impact: Neutral. This non-market transaction does not signal a shift in insider sentiment regarding the company's current valuation.

Company Information

Field	Value
Company	SPRUCE BIOSCIENCES, INC.
Ticker Symbol	SPRB
CIK	0001683553
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Walbert Keli
CIK	0002051489
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-11
Transaction Code	A (Award)
Security Type	Stock Option (Right to Buy)
Shares Involved	3,400
Price Per Share	$0.00
Total Value	$0
Shares Owned After	3,400 (derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	3,400 (options)
% of Shares Outstanding	N/A (data not available)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction has a value of $0 and is a non-cash compensation event for a company with a $110 million market cap. Its immediate financial impact is nil.
• Dilution Impact: The grant represents the right to buy 3,400 shares in the future. As shares outstanding data is not available, a precise dilution percentage cannot be calculated. However, for a company of this size, such a grant typically represents a very minor potential dilution that is spread over the vesting period.
• Transaction Significance: The transaction is a standard equity award to a non-executive director. It is considered routine and carries low significance as it does not reflect an investment decision based on the current market price.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a common form of compensation and are not indicative of an insider's short-term outlook on the stock price. The market typically does not react to such filings.

Volume & Sentiment

• Expected Volume Impact: Negligible. No shares were traded on the open market.
• Sentiment Indicator: Neutral. This filing is informational and does not provide a bullish or bearish signal.

Additional Context

Transaction Notes

• Vesting Schedule: The options vest in equal monthly installments over a three-year period, contingent on the director's continued service. This structure is designed to retain talent and align their interests with long-term shareholders.
• Special Circumstances: The options will fully vest upon a Change in Control of the company.